SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You notice your heart racing or skipping beats. Your doctor checks everything: EKG, echocardiogram, blood work. Sometimes nothing shows up yet. Other times you get a diagnosis of atrial fibrillation, but nobody explains why your heart started misfiring in the first place. The answer isn’t always lifestyle, stress, or aging. Your genes encode the electrical system that keeps your heartbeat steady, and variants in six specific genes can dramatically increase your arrhythmia risk.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Standard cardiology looks at symptoms and acute risk: Do you have high blood pressure? Diabetes? Sleep apnea? Those are real risk factors. But they don’t explain why some people with perfect blood pressure still develop atrial fibrillation, or why others with multiple risk factors stay in normal sinus rhythm. The reason is that your heart’s electrical wiring is partly written into your DNA. When certain genes carry variants, the ion channels and signaling molecules that coordinate your heartbeat become less efficient. Your doctor’s standard tests won’t reveal this because they measure the organ itself, not the cellular machinery running it.
Atrial fibrillation usually isn’t a single point of failure. It’s the product of electrical vulnerability plus a trigger. Your genes control the vulnerability. That vulnerability can remain silent until something stresses the system: an infection, dehydration, alcohol, caffeine, or even a surge in stress hormones. Understanding which genes are loaded means you can stabilize the ones you can control and know exactly which triggers to avoid. This isn’t guesswork based on population averages; it’s precision informed by your actual biology.
Six genes control different aspects of your heart’s electrical and structural function. Some regulate ion channels (the doors that let charged particles in and out of heart cells); others control blood pressure pathways that, when disrupted, create conditions favorable to fibrillation; still others manage the vascular health and inflammation that either protect or threaten the tissue surrounding your heart. Below is how each one works and what you can actually do about it.
Most people with arrhythmia risk don’t carry one broken gene; they carry a combination. One person might have a slow NOS3 and a fast ACE. Another might have both an SCN5A variant and elevated homocysteine from MTHFR. The symptoms look identical: a racing heart, a flutter, the terror of not knowing if the next beat will come. But the interventions are completely different. You cannot know which pathway is driving your risk without testing. Guessing leads to treatments that either miss the target or create new problems.
Atrial fibrillation carries real consequences: stroke risk (from blood pooling in the quivering atrium), heart failure (from chronic irregular beating and inefficient pumping), and the anxiety of living with an unpredictable heartbeat. Standard treatment often starts with blood thinners and rate-control drugs, which are life-saving for many people. But drugs manage symptoms; they don’t address the genetic vulnerability underneath. Worse, some of the most common interventions for atrial fibrillation can backfire if you don’t know your genetic profile. A beta-blocker that calms one person’s racing heart can worsen another’s if that person has a specific ion-channel variant. The only way to move from symptom management to targeted prevention is to know which genes are driving your risk.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
These genes regulate ion channels (the gateways controlling how sodium, potassium, and calcium move in and out of heart cells), nitric oxide signaling (which controls blood vessel dilation), angiotensin pathways (which influence blood pressure and cardiac structure), and homocysteine metabolism (which drives vascular inflammation). Together, they determine your vulnerability to atrial fibrillation.
NOS3 is an enzyme that produces nitric oxide, a molecule that tells your blood vessels to relax and dilate. When blood vessels are supple and responsive, blood flows smoothly and your heart doesn’t have to work harder. Nitric oxide also has direct effects on the heart itself, stabilizing the electrical properties of cardiac tissue and reducing inflammation in the myocardium.
The Glu298Asp variant in NOS3, carried by roughly 30 to 40% of the population, impairs the enzyme’s ability to produce sufficient nitric oxide. People with this variant have chronically stiffer blood vessels and reduced ability to respond to the body’s demand for increased blood flow. The heart compensates by beating faster or harder, and the electrical tissue becomes irritable under stress.
What this feels like: Your heart races easily with mild exertion or emotional stress. You may notice blood pressure creeping up despite being relatively fit. When you’re anxious or sleep-deprived, the irregularities become worse. Your vessels simply cannot dilate enough to accommodate demand smoothly.
People with NOS3 variants often respond well to nitric oxide donors like beet juice or L-citrulline supplements, combined with endothelial-supportive exercise (steady-state cardio rather than intense sprints) and avoidance of stimulants that further constrict vessels.
ACE is a key enzyme in the renin-angiotensin-aldosterone system, a hormonal pathway that controls blood pressure by managing fluid retention and blood vessel constriction. When ACE activity is high, angiotensin II levels rise, blood vessels constrict more aggressively, and your kidneys retain more sodium. High ACE activity also triggers cardiac hypertrophy, meaning the heart muscle thickens in response to the increased workload.
The D allele of the ACE I/D polymorphism, present in roughly 25% of people as the D/D homozygous genotype, is associated with higher ACE activity, higher angiotensin II levels, and chronically elevated blood pressure. Over time, this combination remodels the heart and atria, creating the structural conditions where atrial fibrillation more easily takes hold. The thickened, stiffer atrial tissue becomes electrically unstable.
What this feels like: You develop high blood pressure relatively early, even if you exercise regularly and keep sodium intake moderate. Your left ventricle and atria are working under constant strain. When you’re dehydrated, have excess salt, or experience stress, the pressure spikes further and your heart becomes more irritable. You might notice palpitations especially after salty meals or in hot weather.
ACE D/D carriers benefit dramatically from ACE inhibitors (prescribed by your cardiologist) combined with strict sodium restriction, potassium-rich foods, and magnesium supplementation (400-500 mg daily of glycinate or threonate form) to lower arrhythmia risk.
MTHFR is an enzyme critical to the methylation cycle, a fundamental cellular process that affects DNA synthesis, neurotransmitter production, and detoxification. One of MTHFR’s most important jobs is converting homocysteine into methionine. When MTHFR works poorly, homocysteine accumulates in the bloodstream.
The C677T variant in MTHFR, carried by roughly 40% of people of European ancestry, reduces the enzyme’s efficiency by 40 to 70%. This leads to elevated plasma homocysteine, which damages the endothelial lining of blood vessels, promotes clot formation, and triggers chronic low-grade inflammation in cardiac tissue. High homocysteine is an independent cardiovascular risk factor as powerful as smoking or high cholesterol, yet standard blood work often doesn’t test for it.
What this feels like: You may not feel anything until later, but your arteries are becoming stiffer and your heart tissue more inflamed. Many people with elevated homocysteine have no other obvious risk factors, which is why their cardiologists miss it. The inflammation and vascular damage create fertile ground for arrhythmias to start.
MTHFR C677T carriers must supplement with methylated B vitamins (methylfolate 500-1000 mcg daily, methylcobalamin 500-1000 mcg daily) rather than synthetic folic acid, plus B6 as pyridoxal-5-phosphate to drive homocysteine down and protect vessel walls.
COMT breaks down the stress hormones dopamine, norepinephrine, and epinephrine. When your sympathetic nervous system activates (fight-or-flight response), these hormones surge. COMT’s job is to clear them so your heart rate returns to baseline and your blood pressure comes back down. If COMT works too slowly, these stress hormones linger in your bloodstream, keeping your heart in a state of alert.
The Val158Met polymorphism in COMT affects how quickly the enzyme breaks down these neurotransmitters. Roughly 25% of people of European ancestry are homozygous for the slow variant. Slow COMT means stress hormones stay elevated longer, your sympathetic nervous system stays activated, and your heart stays irritable and prone to irregular beats even after the stressor has passed. The atria, highly sensitive to catecholamine surge, become electrically unstable.
What this feels like: You’re sensitive to caffeine and stimulants. Your heart races or flutters easily with emotional stress, loud noises, or even minor surprises. You startle easily and take longer to calm down after stress. Anxiety and racing thoughts linger even when the threat is gone. At night, your mind won’t turn off, and your heartbeat feels chaotic.
Slow COMT carriers must eliminate or severely restrict caffeine, avoid stimulating supplements, practice daily stress management (meditation, tai chi), and consider magnesium glycinate (400-500 mg evening dose) to reduce sympathetic tone and protect against catecholamine-driven arrhythmias.
SCN5A encodes the alpha-subunit of the cardiac sodium channel, one of the most critical ion channels in the heart. Sodium channels control the rapid influx of sodium that initiates the electrical impulse in each heartbeat. When these channels open and close in perfect synchrony across millions of cells, the heartbeat is coordinated and regular. When they malfunction, electrical signals spread erratically, and the atria fibrillate instead of contracting cleanly.
Variants in SCN5A are responsible for a spectrum of inherited arrhythmia syndromes, including Brugada syndrome and long QT syndrome. Even more subtle SCN5A variants increase atrial fibrillation susceptibility in the general population. People carrying SCN5A variants have sodium channels that open or close too slowly or too quickly, disrupting the precise timing needed for coordinated heartbeats. The atria become electrically unstable, and the risk of fibrillation jumps dramatically under stress, fever, or electrolyte shifts.
What this feels like: Your arrhythmias often appear without obvious trigger, or they’re triggered by things that shouldn’t matter: a slight fever, a missed meal, a change in electrolyte balance from sweating. You may have been told your arrhythmia is “idiopathic” (no clear cause). Your EKG or event monitor shows the electrical pattern disruption clearly, but nobody has explained the genetic mechanism.
SCN5A carriers need strict electrolyte management (adequate sodium, potassium, magnesium, and calcium), avoidance of QT-prolonging drugs, regular monitoring for fever or infection, and often benefit from specific antiarrhythmic medications tailored to their channel dysfunction that a genetic cardiologist can prescribe.
KCNQ1 encodes a potassium channel critical to the repolarization phase of the heartbeat. After a sodium influx depolarizes the heart cell, potassium must flow out to repolarize the cell and prepare it for the next beat. KCNQ1 controls part of this outflow. If the channel doesn’t function properly, repolarization becomes slow or irregular, and the electrical refractory period (the window during which the cell cannot fire again) becomes unpredictable.
Variants in KCNQ1 are a major genetic cause of long QT syndrome (prolonged repolarization), which predisposes to dangerous arrhythmias like Torsades de Pointes. Even in people without diagnosed long QT, KCNQ1 variants increase general atrial fibrillation susceptibility. The atria become electrically chaotic because the recovery phase is too slow, creating overlapping electrical waves that fire out of sync and fibrillate.
What this feels like: Your arrhythmias often spike when your heart rate suddenly changes, when you’re startled, or when you’re exercising. You may have syncope (fainting) episodes, especially during exertion or sudden emotional events. Some people with KCNQ1 variants are completely asymptomatic until they have a dangerous arrhythmia. Standard EKGs may show a prolonged QT interval, which is the clinical hallmark.
KCNQ1 carriers must avoid QT-prolonging medications (many common antibiotics, antipsychotics, and antihistamines), maintain strict electrolyte balance (especially potassium and magnesium), avoid intense heat, and work with a genetic cardiologist who can prescribe beta-blockers or other repolarization-stabilizing medications.
❌ Taking a standard beta-blocker when you have a slow COMT can lower your blood pressure too much and make you fatigued, because you’re already slow to clear stress hormones; you need a different class of rate-control drug or sympathetic management through other means.
❌ Restricting sodium aggressively when you have an SCN5A variant can cause dangerous electrolyte imbalance and actually trigger arrhythmias; you need to maintain sodium and manage other electrolytes precisely.
❌ Supplementing with standard folic acid when you have MTHFR C677T doesn’t lower your homocysteine and may accumulate as unmetabolized folic acid; you must use methylfolate instead.
❌ Avoiding all stress and exercise because you have an NOS3 variant will worsen your endothelial function and increase arrhythmia risk; you need the right type and intensity of cardiovascular training to improve nitric oxide production.
❌ Taking a standard beta-blocker when you have a slow COMT can lower your blood pressure too much and make you fatigued, because you’re already slow to clear stress hormones; you need a different class of rate-control drug or sympathetic management through other means.
❌ Restricting sodium aggressively when you have an SCN5A variant can cause dangerous electrolyte imbalance and actually trigger arrhythmias; you need to maintain sodium and manage other electrolytes precisely.
❌ Supplementing with standard folic acid when you have MTHFR C677T doesn’t lower your homocysteine and may accumulate as unmetabolized folic acid; you must use methylfolate instead.
❌ Avoiding all stress and exercise because you have an NOS3 variant will worsen your endothelial function and increase arrhythmia risk; you need the right type and intensity of cardiovascular training to improve nitric oxide production.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I had my first episode of atrial fibrillation at 42, totally out of the blue. My cardiologist put me on a beta-blocker and told me to reduce stress. I did everything right: exercise, clean diet, meditation. I still had breakthrough arrhythmias every month. My DNA report showed I was carrying NOS3 and ACE D/D variants with elevated homocysteine from MTHFR. That explained everything. I switched to methylated B vitamins, added L-citrulline for nitric oxide support, cut my sodium intake in half, and eliminated caffeine entirely. My cardiologist also adjusted my medication knowing my ACE status. Within two months, no irregular beats. My EKG normalized. I finally understand why my body was behaving this way, and now I’m preventing future episodes instead of just reacting to them.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Yes, absolutely. Atrial fibrillation has strong genetic components. Genes like SCN5A, KCNQ1, NOS3, and ACE directly control the ion channels, blood pressure pathways, and vascular function that determine your heart rhythm stability. If you have variants in even one of these genes, your atria become more vulnerable to fibrillation under stress, dehydration, or electrolyte shifts. Variants in multiple genes (which is common) multiply the risk. Standard EKGs and blood tests won’t reveal this genetic vulnerability; a DNA test will.
Yes. If you already have raw DNA data from 23andMe, AncestryDNA, or another testing company, you can upload that file to SelfDecode within minutes. We’ll analyze your existing genetic data for the six genes that control heart rhythm and provide the same personalized cardiovascular insights. No new cheek swab needed.
Never stop or change a prescribed medication without your cardiologist’s approval. A DNA report helps you and your cardiologist have a more informed conversation. For example, if you learn you carry ACE D/D, your doctor can confirm you’re on an ACE inhibitor (the most appropriate class for your genetics). If you have an MTHFR variant, your doctor can ensure you’re getting methylated B vitamins and tracking homocysteine. If you carry a slow COMT, your cardiologist can choose a rate-control drug that works with your biology rather than against it. The DNA test informs optimization, not replacement, of existing treatment.
See why AI recommends SelfDecode as the best way to understand your DNA and take control of your health:
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.